Fortis Malar Hospitals Reports Narrowed Q3 FY2023 Loss of Rs 1.17 Crore
Fortis Malar Hospitals Limited reported a standalone loss before tax of Rs 1.17 crore for Q3 FY2023, a 56.83% improvement from the Rs 2.71 crore loss in Q3 FY2022. Revenue from operations increased by 7.09% to Rs 21.90 crore. Total expenses were Rs 24.57 crore, with major components including professional charges to doctors, employee benefits, and purchase of medical consumables. The company's EPS was negative at Rs 0.62. Fortis Malar is dealing with a legal matter regarding hospital building regularization, with related expenses to be borne by Fortis Health Management Limited.

*this image is generated using AI for illustrative purposes only.
Fortis Malar Hospitals Limited, a prominent healthcare provider, has released its unaudited financial results for the third quarter ended December 31, 2022, showing a reduction in losses compared to the same period last year.
Financial Performance
The company reported a standalone loss before tax of Rs 1.17 crore for Q3 FY2023, a significant improvement from the Rs 2.71 crore loss recorded in the corresponding quarter of the previous year. This represents a 56.83% reduction in losses year-over-year.
Revenue from operations saw a modest increase, rising to Rs 21.90 crore from Rs 20.45 crore in the same quarter last year, marking a 7.09% growth.
Operational Expenses
Total expenses for the quarter stood at Rs 24.57 crore. The major components of these expenses included:
Expense Category | Amount (Rs in Lakhs) |
---|---|
Professional charges to doctors | 650.87 |
Employee benefits | 487.13 |
Purchase of medical consumables | 291.64 |
Key Financial Metrics
- Earnings per share (EPS) for the quarter was negative at Rs 0.62, reflecting the company's current loss-making position.
- The company's revenue growth, coupled with the narrowed losses, suggests potential improvements in operational efficiency.
Ongoing Litigation
Fortis Malar Hospitals is currently dealing with a legal matter concerning the regularization of its hospital building. The Chennai Metropolitan Development Authority has requested certain clearances and certificates. The company has stated that any expenses related to building regularization will be borne by Fortis Health Management Limited, as per their agreement.
Looking Ahead
While Fortis Malar Hospitals continues to face challenges, the reduction in losses and increase in revenue indicate positive momentum. The company's ability to manage expenses and resolve ongoing legal matters will be crucial for its future financial health and operational stability.
Historical Stock Returns for Fortis Malar Hospitals
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
-0.03% | -0.05% | -4.51% | -9.28% | +9.38% | +32.55% |